Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Clinical trial NCT02186249 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT02186249
- Sponsor
- Bristol-Myers Squibb
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.